Meanwhile, previous studies demonstrated that these inflammatory markers (CRP, IL-6, and soluble adhesion molecules) played an essential role in the development of PAD and predicting adverse outcomes in patients with PAD [7,11,41,42]. The gene discussed is IL6; the disease is peripheral arterial disease.